Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

TSX:CSCI - Post Discussion

COSCIENS Biopharma Inc > Avenanthramide
View:
Post by prophetoffactz on Nov 20, 2024 8:15pm

Avenanthramide

What happened to avenanthramide sales? One possibility is that the amount if avenanthramide was changed after the spin-off from J&J. This could create an opportunity for Juvente.

Perplexity Ai:

Yes, Kenvue has changed the formulation of some Aveeno products since being spun off from Johnson & Johnson
3
5
. The Daily Moisturising Lotion formula was recently modified, with users noting increased petroleum content and different absorption properties
3
. Aveeno's website acknowledges packaging updates but claims the "same nourishing formula" remains
5
, though user experiences suggest otherwise. Some consumers have reported skin irritation and flare-ups with the new formula that they did not experience with the original version
3
.
Be the first to comment on this post